X-57331631-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_174912.4(FAAH2):c.446G>T(p.Arg149Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000504 in 1,209,566 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_174912.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAAH2 | NM_174912.4 | c.446G>T | p.Arg149Leu | missense_variant | 4/11 | ENST00000374900.5 | NP_777572.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAAH2 | ENST00000374900.5 | c.446G>T | p.Arg149Leu | missense_variant | 4/11 | 1 | NM_174912.4 | ENSP00000364035.4 |
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111653Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33859
GnomAD3 exomes AF: 0.000202 AC: 37AN: 182997Hom.: 0 AF XY: 0.000192 AC XY: 13AN XY: 67605
GnomAD4 exome AF: 0.0000501 AC: 55AN: 1097913Hom.: 0 Cov.: 30 AF XY: 0.0000468 AC XY: 17AN XY: 363319
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111653Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33859
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2024 | The c.446G>T (p.R149L) alteration is located in exon 4 (coding exon 4) of the FAAH2 gene. This alteration results from a G to T substitution at nucleotide position 446, causing the arginine (R) at amino acid position 149 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at